Safe Entry Stations
Mitigate risks to your team and to the uninterrupted operation of your business by setting up Safe Entry Stations for infectious disease symptom detection or for impairment detection. Our screening products for infectious disease and impairment are quick, noninvasive, no-contact solutions that can detect a first look indication of symptoms. All it takes is a simple walk-through.
Our Solutions
Our Partners
Our strategic partners help our team make a significant impact on the health and safety of people around the globe. We currently have partnerships in the US, Canada, and South Asia.










Accurate Detection Without Sacrificing Privacy
With multispectral cameras and sensors all functioning with full autonomy, you can screen quickly and easily all while maintaining privacy as a priority. Safe Entry Stations can also be customized for your location for permanent, temporary, and mobile use.

Recent Press
Predictmedix Showcases Safe Entry Station Technology at Major Las Vegas Entertainment Event
Placement at Major Las Vegas Venue Served as Live, High-Profile Demonstration of Safe Entry Station to Area Entertainment and Hospitality Sector Representatives Toronto, ON, April 5, 2022 – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced the conclusion […]
Predictmedix Inc. Issues Shareholder Letter and Provides Corporate Update on Key Milestone Achievements
Toronto, ON, February 10, 2022 – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today released a letter to shareholders from Interim Chief Executive Officer, Dr. Rahul Kushwah. Dear Fellow Shareholders, 2021 was an exciting and transformational year for Predictmedix. […]
Predictmedix To Launch Infectious Diseases Clinical Trial in North American Hospital for FDA Medical Device Classification of Safe Entry Stations
Independent Study for Infectious Diseases Symptom Detection in a Clinical Setting to Provide Additional Third-Party Validation; Prerequisite Ahead of Planned FDA Certification as Class II Medical Device Toronto, ON – January 26, 2022 – Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”), an emerging provider of rapid health screening solutions powered by a proprietary artificial […]